References
- Wang CC, Little JB, Schulz MD. Cancer of the nasopharynx. Its clinical and radiotherapeutic considerations. Cancer 1962;15:921-926 https://doi.org/10.1002/1097-0142(196209/10)15:5<921::AID-CNCR2820150506>3.0.CO;2-3
- Hsu MM, Huang SC, Lynn TC, et al. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 1982;90:289-295
- Johansen LV, Mestre M, Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992;14:200-207 https://doi.org/10.1002/hed.2880140307
- Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994;30:1029-1036 https://doi.org/10.1016/0360-3016(94)90306-9
- Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270 https://doi.org/10.1016/0360-3016(92)90740-9
- Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 1981;7:447-453 https://doi.org/10.1016/0360-3016(81)90129-2
- Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992;23:271-280 https://doi.org/10.1016/0360-3016(92)90741-Y
- Petrovich Z, Cox JD, Middleton R, et al. Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients. Radiother Oncol 1985;4:15-20 https://doi.org/10.1016/S0167-8140(85)80057-8
- Teo P, Tsao SY, Shiu W, et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int J Radiat Oncol Biol Phys 1989;17:515-530 https://doi.org/10.1016/0360-3016(89)90102-8
- Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual 5th ed. Philadelphia; Lippincott-Raven, 1997
- Ho JHC. Stage classification of nasopharyngeal carcinoma: a review. In: De The G, Eto Y, editors. Nasopharyngeal carcinoma: etiology and control. IARC Scientific Pub. No. 20. Lyon: International Agency for Research on Cancer, 1978:99-113
- Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994;30:1037-1042 https://doi.org/10.1016/0360-3016(94)90307-7
- Lee S, Kim GE, Suh CO, Lee KK, Park W. A Comparison of T classification of the AJCC and Ho staging systems for nasopharyngeal carcinoma. Kor J Head Neck Oncol 2002;18:179-183
- Kao CH, ChangLai SP, Chieng PU, et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550-3555 https://doi.org/10.1200/JCO.1998.16.11.3550
- Kao CH, Hsieh JF, Tsai SC, et al. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000;109:1130-1134 https://doi.org/10.1177/000348940010901209
- Tsai MH, Shiau YC, Kao CH, et al. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002;128:279-282 https://doi.org/10.1007/s00432-002-0341-6
- Kao CH, Shiau YC, Shen YY, et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 2002;94:1981-1986 https://doi.org/10.1002/cncr.10400
- Terhaard CH, Bongers V, van Rijk PP, et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933-941 https://doi.org/10.1002/hed.1135
- Sakamoto H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol Suppl 1998;538:254-260 https://doi.org/10.1080/00016489850183034
- Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002;24:127-135 https://doi.org/10.1002/hed.10037
- Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211 https://doi.org/10.1148/radiology.197.1.7568825
- Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:455-464 https://doi.org/10.1016/0360-3016(93)90259-X
- Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141 https://doi.org/10.1148/radiology.200.1.8657901
- Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135-139 https://doi.org/10.1288/00005537-199502000-00004
- Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relBlood flow and metabolism in locally advanced breast cancer: relationship to response to therapyationship to response to therapy. J Nucl Med 2002;43:500-509
- Eary JF, O'Sullivan F, Powitan Y, et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 2002;29:1149-1154 https://doi.org/10.1007/s00259-002-0859-5
- Kitagawa Y, Sano K, Nishizawa S, et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 2003;30:63-71 https://doi.org/10.1007/s00259-002-0978-z
- Spence AM, Muzi M, Krohn KA. Molecular imaging of regional brain tumor biology. J Cell Biochem 2002;39(Suppl):25-35 https://doi.org/10.1002/jcb.10406
- Oshida M, Uno K, Suzuki M, et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose. Cancer 1998;82:2227-2234 https://doi.org/10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W
- Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201-3206 https://doi.org/10.1200/JCO.1999.17.10.3201
- Halfpenny W, Hain SF, Biassoni L, et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002;86:512-516 https://doi.org/10.1038/sj.bjc.6600114
- Ahuja V, Coleman RE, Herndon J, et al. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918-924 https://doi.org/10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y
- Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-1220
- Schulte M, Brecht-Krauss D, Heymer B, et al. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med 1999;26:599-605 https://doi.org/10.1007/s002590050427
- Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000;41:1695-1701
- Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000;41:85-92
- Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-3844
- Yang Y, Kim JS, Kim SY, et al. Comparison of 18F FDG-PET and CT/MRI for the diagnosis of cervical lymph node metastasis in head and neck cancer: a level-by-level based study. Kor J Nucl Med 2004;38:52-61
- Lee S, Kim JS, Ryu JS, et al. Evaluation of the response of radiotherapy to squamous cell carcinoma of the head and neck using 18FDG-PET. Kor J Head Neck Oncol 2003;19:58-62
- Lee S, Kim JS, Im KC, et al. Change of FDG uptake according to radiation dose on squamous cell carcinoma of the head and neck. J Korean Soc Ther Radiol 2004;22:98-107
- Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 https://doi.org/10.1200/JCO.1998.16.4.1310
- Hoekstra CJ, Paglianiti I, Hoekstra OS, et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 2000;27:731-743 https://doi.org/10.1007/s002590050570
- Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000;27:643-646 https://doi.org/10.1016/S0969-8051(00)00155-4
- Larson SM, Weiden PL, Grunbaum Z, et al. Positron imaging feasibility studies. II: characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communi cation. J Nucl Med 1981;22:875-879
- Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluations with FDG. J Nucl Med 1991;32:1555-1558
- Wahl RL, Hutchins GD, Buchsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positronemission tomography. Cancer 1991;67:1544-1550 https://doi.org/10.1002/1097-0142(19910315)67:6<1544::AID-CNCR2820670614>3.0.CO;2-0
- Sigurdson ER CA. Commentary on 'The applications of PET in clinical oncology'. J Nucl Med 1991;32:649-650
- Lyon RC, Cohen JS, Faustino PJ, et al. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res 1988;48:870-877
- Folpe AL, Lyles RH, Sprouse JT, et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000;6: 1279-1287
- Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20:1398-1404 https://doi.org/10.1200/JCO.20.5.1398
- Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997;38:1907-1911